Search research articles
Contact Us
Filters
Showing results (41-50 of 83) with videos related to
Page
of 9
Sort By:
International Journal of Clinical Pharmacy
|
July 12, 2011
Induction-related cost of patients with acute myeloid leukaemia in France
Virginie Nerich, Bruno Lioure, Maryline Rave, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2012
A multicenter phase II study of single-agent enzastaurin in previously treated Waldenstrom macroglobulinemia
Irene M Ghobrial, Philippe Moreau, Brianna Harris, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 6, 2018
Interim PET Response-adapted Strategy in Untreated Advanced Stage Hodgkin Lymphoma: Results of GOELAMS LH 2007 Phase 2 Multicentric Trial
Sylvain Carras, Benjamin Dubois, Delphine Senecal, et al.
British Journal of Haematology
|
July 31, 2021
Updated results of the placebo-controlled, phase III JAKARTA trial of fedratinib in patients with intermediate-2 or high-risk myelofibrosis
Animesh Pardanani, Ayalew Tefferi, Tamás Masszi, et al.
American Journal of Hematology
|
March 12, 2014
Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA
Nicolas Duployez, Olivier Nibourel, Alice Marceau-Renaut, et al.
Leukemia Research
|
December 3, 2014
A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure
Sylvain Thepot, Simone Boehrer, Valérie Seegers, et al.
Blood
|
March 7, 2007
Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma
Karène Mahtouk, Dirk Hose, Pierre Raynaud, et al.
Blood
|
September 2, 2006
CD200 is a new prognostic factor in multiple myeloma
Jerome Moreaux, Dirk Hose, Thierry Reme, et al.
NAR Genomics and Bioinformatics
|
September 25, 2024
Effective requesting method to detect fusion transcripts in chronic myelomonocytic leukemia RNA-seq
Florence Rufflé, Jérôme Reboul, Anthony Boureux, et al.
British Journal of Haematology
|
April 22, 2005
One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remission
Eric Jourdan, Françoise Rigal-Huguet, Gerald Marit, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 83) with videos related to
Sort By:
Page
of 9
International Journal of Clinical Pharmacy
|
July 12, 2011
Induction-related cost of patients with acute myeloid leukaemia in France
Virginie Nerich, Bruno Lioure, Maryline Rave, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2012
A multicenter phase II study of single-agent enzastaurin in previously treated Waldenstrom macroglobulinemia
Irene M Ghobrial, Philippe Moreau, Brianna Harris, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 6, 2018
Interim PET Response-adapted Strategy in Untreated Advanced Stage Hodgkin Lymphoma: Results of GOELAMS LH 2007 Phase 2 Multicentric Trial
Sylvain Carras, Benjamin Dubois, Delphine Senecal, et al.
British Journal of Haematology
|
July 31, 2021
Updated results of the placebo-controlled, phase III JAKARTA trial of fedratinib in patients with intermediate-2 or high-risk myelofibrosis
Animesh Pardanani, Ayalew Tefferi, Tamás Masszi, et al.
American Journal of Hematology
|
March 12, 2014
Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA
Nicolas Duployez, Olivier Nibourel, Alice Marceau-Renaut, et al.
Leukemia Research
|
December 3, 2014
A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure
Sylvain Thepot, Simone Boehrer, Valérie Seegers, et al.
Blood
|
March 7, 2007
Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma
Karène Mahtouk, Dirk Hose, Pierre Raynaud, et al.
Blood
|
September 2, 2006
CD200 is a new prognostic factor in multiple myeloma
Jerome Moreaux, Dirk Hose, Thierry Reme, et al.
NAR Genomics and Bioinformatics
|
September 25, 2024
Effective requesting method to detect fusion transcripts in chronic myelomonocytic leukemia RNA-seq
Florence Rufflé, Jérôme Reboul, Anthony Boureux, et al.
British Journal of Haematology
|
April 22, 2005
One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remission
Eric Jourdan, Françoise Rigal-Huguet, Gerald Marit, et al.
Page
of 9